FESTI, GIULIANA
 Distribuzione geografica
Continente #
EU - Europa 253
NA - Nord America 210
AS - Asia 198
SA - Sud America 27
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 694
Nazione #
US - Stati Uniti d'America 205
RU - Federazione Russa 144
SG - Singapore 93
CN - Cina 49
IT - Italia 26
BR - Brasile 23
DE - Germania 21
HK - Hong Kong 21
VN - Vietnam 15
FR - Francia 13
SE - Svezia 13
IE - Irlanda 12
GB - Regno Unito 7
FI - Finlandia 6
KR - Corea 6
IN - India 4
AT - Austria 3
CA - Canada 3
JP - Giappone 3
BE - Belgio 2
ES - Italia 2
MA - Marocco 2
MX - Messico 2
PK - Pakistan 2
PL - Polonia 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
CL - Cile 1
CO - Colombia 1
ID - Indonesia 1
IQ - Iraq 1
KE - Kenya 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 694
Città #
Moscow 54
Singapore 50
Chandler 28
Ashburn 25
Hong Kong 20
Dallas 19
New York 15
Beijing 13
Dublin 12
Jacksonville 6
Munich 6
Redondo Beach 6
Southend 6
Bologna 5
Lawrence 5
Princeton 5
Frankfurt am Main 4
Guangzhou 4
Ho Chi Minh City 4
Phoenix 4
Sindelfingen 4
Turku 4
Verona 4
Ann Arbor 3
Hebei 3
Jinan 3
Los Angeles 3
Nanjing 3
Nuremberg 3
Shenyang 3
Vancouver 3
Wilmington 3
Bari 2
Brooklyn 2
Brussels 2
Delhi 2
Denver 2
Haiphong 2
Hanoi 2
Lomé 2
Ningbo 2
Redmond 2
San Jose 2
Santa Clara 2
Seattle 2
São Paulo 2
Tokyo 2
Warsaw 2
Anapa 1
Aracruz 1
Asunción 1
Atlanta 1
Bandung 1
Basra 1
Belo Horizonte 1
Biên Hòa 1
Buzău 1
Camaçari 1
Can Tho 1
Castiglione delle Stiviere 1
Central 1
Charlotte 1
Chennai 1
Chicago 1
Colorado 1
Columbus 1
Cruz Alta 1
Curitiba 1
Da Nang 1
Fes 1
Formigueiro 1
Fuzhou 1
Haikou 1
Hamanocho 1
Hangzhou 1
Helsinki 1
Huzhou 1
Intendente Alvear 1
Itajaí 1
Itapeva 1
Jubail 1
Jundiaí 1
Kent 1
Lahore 1
Lancaster 1
Lappeenranta 1
Las Vegas 1
Macaé 1
Manassas 1
Manila 1
McKenzie 1
Meknes 1
Mercês 1
Milan 1
Montebelluna 1
Mumbai 1
Nairobi 1
Natal 1
Norwalk 1
Orem 1
Totale 414
Nome #
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 124
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 114
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 109
Relevance of TH2 markers in the assessment and therapeutic management of severe allergic asthma: A real-life perspective 101
Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy 96
One-year mepolizumab for Allergic bronchopulmonary aspergillosis: Focus on steroid sparing effect and markers of response 92
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 70
Totale 706
Categoria #
all - tutte 2.986
article - articoli 2.986
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.972


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 2 0 0 0 0 2 0
2021/202243 11 11 1 5 0 0 1 2 2 2 1 7
2022/202393 8 5 12 8 11 19 3 4 17 1 3 2
2023/202451 4 4 4 6 3 14 4 1 1 0 9 1
2024/2025161 18 8 9 16 7 5 6 8 27 8 16 33
2025/2026316 34 23 23 73 130 33 0 0 0 0 0 0
Totale 706